Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Interpace Biosciences Inc (IDXG)  
$1.37 0.02 (1.33%) as of 4:30 Wed 5/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 38,196,000
Market Cap: 52.25(M)
Last Volume: 52,373 Avg Vol: 51,791
52 Week Range: $0.83 - $2.91
Level I Sector: Industrials
Level II Sector: Diversified Services
Level III Sector: Business Services

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ INDUSTRIAL
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Interpace Biosciences engages in oncology by providing services from early diagnosis and prognostic planning to targeted therapeutic applications through its clinical and pharma services. Co.'s commercialized molecular diagnostic tests include: PancraGEN®, which is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians assess risk of pancreaticobiliary cancers using its PathFinderTG® platform; and PanDNA, a molecular only version of PancraGEN® that provides physicians a snapshot of a limited number of factors. Through its pharma services, Co. provides ancillary services, including: biorepository, clinical trial logistics, and clinical trial design.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 69
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mccarthy Christopher Chief Financial Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 10,000 45,644     -
   Mccarthy Christopher Chief Financial Officer   •       –      –    2023-07-31 4 A $0.00 $0 D/D 25,000 35,644     -
   Mccarthy Christopher Principal Financial OfficerOff   •       –      –    2023-04-21 3 IO $0.00 $0 D/D 0 7,310 10%     
   Burnell Thomas W. President & CEO   •       •      –    2021-05-21 4 B $8.68 $94,221 I/I 10,855 10,855 2.66 5%     
   Freeburg Thomas John Chief Financial Officer   •       –      –    2021-03-10 4 A $0.00 $0 D/D 50,000 52,000     -
   Kamin Peter H 10% Owner   –       –       •   2021-03-01 4 B $3.08 $79,587 I/I 25,840 44,670 1.5 234%     
   Kamin Peter H 10% Owner   –       –       •   2021-03-01 4 B $3.08 $50,389 D/D 16,360 270,108 2.45 234%     
   Kamin Peter H 10% Owner   –       –       •   2021-02-26 4 B $3.17 $82,750 I/I 26,104 41,808 1.5 227%     
   Kamin Peter H 10% Owner   –       –       •   2021-02-26 4 B $3.17 $47,379 D/D 14,946 253,748 2.37 227%     
   Kamin Peter H 10% Owner   –       –       •   2021-02-18 3 IO $0.00 $0 I/I 0 511,848 153%     
   Kamin Peter H 10% Owner   –       –       •   2021-02-18 3 IO $0.00 $0 D/D 0 270,108 153%     
   Gorman Robert J. Director   –       •      –    2021-01-29 4 A $4.02 $50,001 D/D 12,438 18,759     -
   Burnell Thomas W. President and CEO   •       •      –    2020-12-01 4 A $0.00 $0 D/D 225,000 225,000     -
   Early James Former Chief Financial Officer   –       –      –    2020-07-29 4 OE $0.00 $0 D/D 5,000 7,125     -
   Stover Jack E President and CEO   •       •      –    2020-03-12 4 A $0.00 $0 D/D 7,188 30,271     -
   Marcet Pablo Director   –       •      –    2020-02-01 3 IO $0.00 $0 I/I 0 7,000 -34%     
   Lampe-Onnerud Christina Director   –       •      –    2020-02-01 4 A $0.00 $0 D/D 2,391 2,391     -
   Marcet Pablo Director   –       •      –    2020-02-01 4 A $0.00 $0 D/D 2,391 2,391     -
   Gorman Robert J. Director   –       •      –    2020-01-29 4 A $7.91 $49,999 D/D 6,321 6,321     -
   Richard Gregory Chief Commerical Officer   •       –      –    2019-03-13 4 A $0.00 $0 D/D 39,528 84,169     -
   Freeburg Thomas John Chief Accounting Officer   •       –      –    2019-03-13 4 A $0.00 $0 D/D 2,000 2,000     -
   Stover Jack E President and CEO   •       •      –    2019-03-13 4 A $0.00 $0 D/D 86,922 427,300     -
   Early James Chief Financial Officer   •       –      –    2019-03-13 4 A $0.00 $0 D/D 26,340 43,340     -
   Early James Chief Financial Officer   •       –      –    2018-12-05 4/A A $0.00 $0 D/D 3,000 17,000     -
   Stover Jack E President and CEO   •       •      –    2018-12-05 4/A A $0.00 $0 D/D 87,000 340,378     -

  69 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed